[Therapeutic effect of lactulose on shunt encephalopathy and blood ammonia concentration in cirrhosis patients].
D000328:Adult; D000641:Ammonia / Q000097:blood*; D001927:Brain Diseases / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D005632:Fructose / Q000627:therapeutic use; D005690:Galactose / Q000627:therapeutic use; D006801:Humans; D007659:Ketones / Q000627:therapeutic use; D007785:Lactose / Q000627:therapeutic use*; D008102:Liver Circulation; D008103:Liver Cirrhosis / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000601:surgery; D008297:Male; D008875:Middle Aged; D011167:Portacaval Shunt, Surgical; D011168:Portal System / Q000503:physiopathology
D007659:Ketones; D005632:Fructose; D000641:Ammonia; D007785:Lactose; D005690:Galactose
Untersuchungen zur therapeutischen Wirkung der Laktulose auf die Shunt-Enzephalopathie und die blutammoniak-Konzentration bei Zirrhosekranken.